R.E.M.S. technology reaches the oceanic continent.

We are proud to announce the achievement of sales authorization for the Echolight products issued by the Australia Government Department of Health. So Australia is also opening its doors to R.E.M.S. (Radiofrequency Echographic Multi Spectrometry) bringing the presence of Echolight to over 40 countries around the world.

R.E.M.S. is the innovative technology running the operation of the EchoS densitometer which performs in a few minutes an ultrasound scan of the bone without radiation, delivers the report in real time being able to check the bone health status and then reduce the risk of fragility fracture, as a consequence of osteoporosis.

Being now used in hundreds of hospitals and clinical centers around the world, the device is also available in Australia thanks to the collaboration with an important local partner with the purpose of introducing a new concept of bone health, based on prevention, early diagnosis and bone structure monitoring

Echolight joins NOF

Echolight joins NOF

Echolight joins National Osteoporosis Foundation's Corporate Advisory Roundtable Innovator in bone density diagnostic technology brings expertise to foundation. SEATTLE, Feb. 23, 2021 /PRNewswire/ -- Echolight Medical, manufacturer of the radiation-free EchoS portable...

leggi tutto
REMS technology enters Wikipedia

REMS technology enters Wikipedia

Radiofrequency Echographic Multi Spectrometry officially enters Wikipedia. Echolight is pleased to announce that REMS technology enters Wikipedia, the free, online and collaborative Encyclopedia, which thanks to the contribution of volunteers from around the world is...

leggi tutto
Echolight in Japan

Echolight in Japan

Obtaining the prestigious PMDA certification in Japan. After more than two years of intense work, we are proud to announce the obtaining of the prestigious authorization to sell for EchoS device in Japan issued by the PMDA Japan: Pharmaceuticals and Medical Devices...

leggi tutto
Share This